Fabry disease trials in Canada

2 of 4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry Disease

  Where

  Halifax, Montreal

  Age

  18 years to 60 years

  People

  16 worldwide

  Run by

  Idorsia Pharmaceuticals Ltd.

  See details and how to joinNCT07778667 · EU 2026-525207-27-00
• No phaseTaking people
  Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

  Where

  Toronto

  Age

  18 years and over

  People

  300

  Run by

  University Health Network, Toronto

  See details and how to joinNCT04856059